Neogen Corp. (NASDAQ:NEOG) was up 3% during trading on Tuesday . The company traded as high as $60.56 and last traded at $58.45, with a volume of 219,692 shares. The stock had previously closed at $56.77.

A number of equities research analysts recently commented on NEOG shares. Zacks Investment Research cut shares of Neogen Corp. from a “hold” rating to a “sell” rating in a report on Thursday, March 24th. Craig Hallum lowered their price target on shares of Neogen Corp. from $65.00 to $49.00 and set a “hold” rating on the stock in a report on Friday, March 25th. Janney Montgomery Scott lowered their price target on shares of Neogen Corp. to $52.00 and set a “neutral” rating on the stock in a report on Friday, March 25th. Finally, Roth Capital reaffirmed a “buy” rating on shares of Neogen Corp. in a report on Thursday, March 24th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $57.25.

The firm’s 50-day moving average price is $54.11 and its 200-day moving average price is $50.80. The firm has a market capitalization of $2.15 billion and a price-to-earnings ratio of 59.57.

Neogen Corp. (NASDAQ:NEOG) last posted its quarterly earnings results on Tuesday, July 19th. The company reported $0.26 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.26. The firm had revenue of $90.10 million for the quarter, compared to analysts’ expectations of $86.27 million. Equities research analysts predict that Neogen Corp. will post $0.97 earnings per share for the current fiscal year.

In related news, Director Jack C. Parnell sold 4,000 shares of the stock in a transaction that occurred on Tuesday, May 10th. The shares were sold at an average price of $49.17, for a total transaction of $196,680.00. Following the transaction, the director now owns 18,568 shares in the company, valued at $912,988.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Crowder sold 27,250 shares of the stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $48.05, for a total transaction of $1,309,362.50. Following the transaction, the director now owns 12,750 shares in the company, valued at approximately $612,637.50. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors recently modified their holdings of the stock. State of Tennessee Treasury Department bought a new position in shares of Neogen Corp. during the fourth quarter worth $1,619,000. Cambridge Investment Research Advisors Inc. increased its position in shares of Neogen Corp. by 2.8% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 24,531 shares of the company’s stock worth $1,386,000 after buying an additional 676 shares during the period. Principal Financial Group Inc. increased its position in shares of Neogen Corp. by 4.5% in the fourth quarter. Principal Financial Group Inc. now owns 253,640 shares of the company’s stock worth $14,335,000 after buying an additional 10,966 shares during the period. Sawtooth Asset Management Inc. increased its position in shares of Neogen Corp. by 21,911.6% in the fourth quarter. Sawtooth Asset Management Inc. now owns 32,357 shares of the company’s stock worth $1,829,000 after buying an additional 32,210 shares during the period. Finally, Mutual of America Capital Management LLC increased its position in shares of Neogen Corp. by 0.6% in the fourth quarter. Mutual of America Capital Management LLC now owns 48,182 shares of the company’s stock worth $2,723,000 after buying an additional 285 shares during the period.

Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company has two segments: Food Safety and Animal Safety. The Food Safety segment is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.